TL;DR
The pathogenic mechanisms associated with U2 AF1 in different malignant diseases were summarized, the potential of related targeting agents was discussed, and the feasibility of natural product-based therapies directed against U2AF1 was explored.
AI-generated by Semantic Scholar
Authors
Qing Nian, Yihui Li, Jingwei Li, Liyun Zhao, Fernando Lima, Jinhao Zeng, Rongxing Liu, Zhijun Ye
